Medigene AG - ESG Rating & Company Profile powered by AI
Check the bottom of this webpage for potential risks for Medigene AG based on industry, geography and size. Complete Sustainability analysis of Medigene AG can be accessed by logging in. The webpage contains a questions and answers section about Medigene AG.
Medigene AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 8.0.
7.5
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
| 149 | Virbac SA | 7.6 | High |
| 160 | Medigene AG | 7.5 | High |
| 160 | C4X Discovery Holdings PLC | 7.5 | High |
| 160 | Ascentage Pharma Group International | 7.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Medigene AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Medigene AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Medigene AG report the average age of the workforce?
Sign up for free to unlockDoes Medigene AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Medigene AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Medigene AG disclose cybersecurity risks?
Sign up for free to unlockDoes Medigene AG offer flexible work?
Sign up for free to unlockDoes Medigene AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Medigene AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Medigene AG conduct supply chain audits?
Sign up for free to unlockDoes Medigene AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Medigene AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Medigene AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Medigene AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Medigene AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Medigene AG disclose water use targets?
Sign up for free to unlockDoes Medigene AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Medigene AG have a product recall in the last two years?
Sign up for free to unlockDoes Medigene AG disclose incidents of discrimination?
Sign up for free to unlockDoes Medigene AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Medigene AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Medigene AG disclose parental leave metrics?
Sign up for free to unlockDoes Medigene AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Medigene AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Medigene AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Medigene AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Medigene AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Medigene AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Medigene AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Medigene AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Medigene AG disclose its waste policy?
Sign up for free to unlockDoes Medigene AG report according to TCFD requirements?
Sign up for free to unlockDoes Medigene AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Medigene AG disclose energy use targets?
Sign up for free to unlockDoes Medigene AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Medigene AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Medigene AG
These potential risks are based on the size, segment and geographies of the company.
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.